Transaction in Own Shares
Summary by AI BETAClose X
13 April 2026
Craneware plc
("Craneware" or the "Company" or the "Group")
Transaction in Own Shares
Craneware (AIM: CRW.L), a leader in healthcare financial performance solutions, announces today it has purchased the following number of its Ordinary Shares of 1 pence each through Investec Bank plc ("Investec") in the period from 7 April 2026 to 9 April 2026.
The table below contains detailed information about the purchases made as part of the buyback programme which was announced by the Company on 16 March 2026 (the "Programme").
|
Date |
Venue |
Volume-weighted average price (p) |
Aggregated volume |
Lowest price per share (p) |
Highest price per share (p) |
|
07 April 2026 |
AIMX |
1384.0000 |
3,778 |
1384.0000 |
1384.0000 |
|
07 April 2026 |
XLON |
1374.3312 |
1,703 |
1344.0000 |
1384.0000 |
|
09 April 2026 |
AIMX |
1390.7159 |
24,731 |
1374.0000 |
1402.0000 |
|
09 April 2026 |
XLON |
1391.8684 |
10,519 |
1374.0000 |
1422.0000 |
The Company intends to hold the purchased shares in Treasury.
Following the above transactions, the Company will hold 580,290 Ordinary Shares in Treasury and has 34,961,879 Ordinary Shares in issue (excluding Treasury shares).
The figure of 34,961,879 represents the total voting rights in the Company and may be used by shareholders as the denominator for calculating whether they are required to notify their interest in, or a change to their interest in, the Company under the FCA's Disclosure Guidance and Transparency Rules.
Individual Transactions
In accordance with Article 5(1)(b) of the Market Abuse Regulation (EU) No 596/2014 as it forms part of UK law, a full breakdown of the individual trades made by Investec on behalf of the Company as part of the buyback programme is attached to this announcement.
http://www.rns-pdf.londonstockexchange.com/rns/1488A_1-2026-4-12.pdf
For further information please contact:
|
Craneware plc |
+44 (0)131 550 3100 |
|
Keith Neilson, CEO |
|
|
Craig Preston, CFO
|
|
|
|
|
|
Alma Strategic Communications |
+44 (0)20 3405 0205 |
|
Caroline Forde, Kinvara Verdon, Louisa El-Ahwal |
craneware@almastrategic.com |
|
|
|
|
|
|
About Craneware
For over 25 years, The Craneware Group (AIM:CRW.L) has been a leader in healthcare financial and operational transformation, delivering cutting-edge technologies that drive measurable impact. Our Trisus® cloud ecosystem unifies data, revenue intelligence, margin intelligence, and advanced analytics, enabling healthcare organizations to optimize performance, improve financial sustainability, and drive strategic growth. As a trusted Microsoft partner, we provide future-ready solutions-including the Best in KLAS Trisus Chargemaster - that simplify the complexities of healthcare finance and operations. What sets us apart is our unique combination of deep healthcare expertise and engineering excellence, positioning us as a strategic partner rather than just a technology provider. The Craneware Group empowers healthcare organizations to achieve sustainable financial success while delivering better outcomes for the communities they serve - today and in the future. Together, we are transforming the business of healthcare.
Learn more at www.thecranewaregroup.com
RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
Latest directors dealings
- 8 hours ago BP
- 8 hours ago Vesuvius
- 8 hours ago Vesuvius
- 9 hours ago Aberdeen Group plc
- 10 hours ago Reach